比较体积稳定型胶原基质与自体结缔组织移植物用于种植位点软组织增量的随机对照临床研究:线体积软组织变化至3个月
在20例患者中比较体积稳定型胶原基质(VCMX)与自体上皮下结缔组织移植物(SCTG)用于种植位点软组织增量的效果。至90天时,两组在牙冠区和颊侧兴趣区的线体积变化差异均无统计学意义,VCMX相较于SCTG在两组兴趣区均得出非劣效结论。作者认为两种方法均可用于种植位点软组织增量,至少带来短期体积增加。
要点
- VCMX与SCTG在种植位点软组织增量中均带来短期体积增加。
- 至90天时,牙冠区和颊侧兴趣区的两组间差异均无统计学意义。
- VCMX相较于SCTG在两组兴趣区均得出非劣效结论。
核心结论
- VCMX与SCTG均可用于种植位点软组织增量,至少带来短期体积增加。
研究设计与样本
- 在20例患者中,于种植位点使用VCMX或SCTG进行软组织增量。
- 在增量前(BL)、30天(FU-30)和90天(FU-90)获取的模型被数字化并转换为立体光刻(STL)文件。
- 将BL、FU-30和FU-90的STL文件叠加,评估牙冠区和颊侧兴趣区(ROI)的线体积变化。
- 对两组进行描述性分析,并进行非劣效性检验。
主要发现
- 从BL到FU-90,牙冠区ROI的中位线变化在VCMX组为0.175 mm(0.06; 0.51)(随时间p=0.002),在SCTG组为0.51 mm(0.23; 0.94)(p=0.129)。
- 两组间差异无统计学意义(p=0.287)。
- 颊侧ROI的相应值在VCMX组为0.59 mm(0.26; 1.06)(p=0.002),在SCTG组为0.94 mm(0.66; 1.13)(p=0.004)。
- 两组间差异无统计学意义(牙冠区:p=0.287;颊侧:p=0.534)。
- VCMX相较于SCTG在两组ROI均得出非劣效结论。
关键数值与推荐
- 从BL到FU-90,牙冠区ROI的中位线变化:VCMX组0.175 mm(0.06; 0.51)(p=0.002),SCTG组0.51 mm(0.23; 0.94)(p=0.129)。
- 从BL到FU-90,颊侧ROI的中位线变化:VCMX组0.59 mm(0.26; 1.06)(p=0.002),SCTG组0.94 mm(0.66; 1.13)(p=0.004)。
- 两组间差异无统计学意义:牙冠区p=0.287,颊侧p=0.534。
- VCMX相较于SCTG在牙冠区和颊侧ROI均得出非劣效结论。
临床怎么用
- VCMX和SCTG可用于种植位点软组织增量,至少带来短期体积增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To test whether or not the use of a volume-stable collagen matrix (VCMX) results in soft tissue volume increase at implant sites non-inferior to an autogenous subepithelial connective tissue graft (SCTG). METHODS: In 20 patients, soft tissue augmentation at implant sites was performed using VCMX or SCTG. Casts obtained prior to augmentation (BL), at 30 (FU-30) and 90 days (FU-90) were digitized and transferred to stereolithography (STL) files. BL, FU-30 and FU-90 STL files were superimposed and linear volumetric changes evaluated in crestal and buccal regions of interest (ROI). Descriptive analysis was computed for both groups and a test for non-inferiority was performed. RESULTS: The median linear changes from BL to FU-90 in the crestal ROI amounted to 0.175 mm (0.06; 0.51) for VCMX (p = 0.002 over time) and to 0.51 mm (0.23; 0.94) for SCTG (p = 0.129). The differences between the two groups were not significant (p = 0.287). The respective values in the buccal ROI were 0.59 mm (0.26; 1.06) for VCMX (p = 0.002) and 0.94 mm (0.66; 1.13) for SCTG (p = 0.004). The differences between the two groups were not significant (crestal: p = 0.287; buccal: p = 0.534). Non-inferiority could be concluded for VCMX compared to SCTG for both ROI. CONCLUSION: VCMX and SCTG can be used for soft tissue augmentation at implant sites resulting in an at least short-term increase in volume.
引用
- Zeltner M, Jung RE, Hämmerle CH, et al. Randomized controlled clinical study comparing a volume-stable collagen matrix to autogenous connective tissue grafts for soft tissue augmentation at implant sites: linear volumetric soft tissue changes up to 3 months. J Clin Periodontol. 2017. PMID: 28107560. doi:10.1111/jcpe.12697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。